Associated Papers
Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease.
Wolff JH et al.
Nature Communications, 2025
40796771 (PubMed )
Supplement: 41467_2025_62738_MOESM1_ESM.pdf
Characterization of missense mutations in the NADPH oxidase partner p22phox in the A22° subtype of chronic granulomatous disease.
Kawai C et al.
Microbiology and Immunology, 2023
Regulation of Derlin-1-mediated degradation of NADPH oxidase partner p22phox by thiol modification.
Miyano K et al.
Redox Biology, 2022
Select a paper to view details